Gene Query: CDC42BPA

Dataset Description Geneva Score
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 122.63
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 75.61
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 62.81
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 54.83
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 50.02
Primate transcript and protein expression levels evolve under compensatory selection pressures 44.1
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 43.57
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 41.34
RNA sequencing of mechanically strained NHEKs and control NHEKs 39.56
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 38.92
The pause-initiation limit restricts transcription activation in human cells 36.81
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 36.5
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 36.14
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 35.85
Expression data from miR340 overexpressing human A549 cells 33.95
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 32.2
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 30.93
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 30.58
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 28.23
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 28.09
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 27.49
MYCi975 regulates MYC target genes 27.46
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 26.64
RNAseq Study in CC-671 Treated Cal-51 Cells 26.13
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 24.31
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 24.14
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 24.1
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 23.27
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 23.21
Differentially expressed genes post knock down of lincDUSP26 23.15
Transcriptional profiling of microglia; current state of the art and future perspectives 22.96
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 22.69
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 22.09
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 22.09
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 21.62
Ribosomal footprinting of CN34-Parental and CN34-LM1a 21.62
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 21.37
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 20.69
High-throughput sequencing of PROMPT-enriched samples. 20.27
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 19.9
Human cell line and subcutaneous tumor 19.71
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 19.61
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 19.49
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 19.18
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 19.01
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 18.86
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 18.52
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 18.5
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 18.29
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 18.2
Ribosomal footprinting of MDA-Parental and MDA-LM2 18.06
Short and Long RNA sequencing of human mature erythrocytes 18.05
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 18.0
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 17.82
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 17.81
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 17.81
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 17.78
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 17.78
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 17.71
Recovery and analysis of nascent RNA 17.71
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 17.65
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 17.65
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 17.61
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 17.6
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 17.58
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 17.46
RNA-Seq from early time points in the kidney differentiation protocol 17.27
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 17.2
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 17.13
FOXD3 is a novel tumor suppressor in lung cancer 17.03
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 16.94
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 16.83
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 16.82
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 16.64
RNA sequencing of GlyH-101-treated MCF-7 cell line 16.44
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 16.34
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 16.23
A Unique Epigenomic Landscape Defines Human Erythropoiesis 16.19
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 16.19
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 16.1
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 16.05
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 15.82
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 15.8
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 15.8
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 15.62
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 15.56
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 15.52
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 15.47
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 15.47
Determination of tRNA aminoacylation levels by high throughput sequencing 15.4
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 15.14
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 15.02
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 14.93
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 14.92
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 14.92
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 14.91
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 14.89
The Genomic Landscape of Atypical Fibroxanthoma 14.89
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 14.87
Exploring ILF2 regulatory genes by next-generation sequencing 14.73
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 14.21
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 14.21
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 14.13
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 14.09
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 14.09
MCF10A H-Ras RNA-Seq 13.95
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 13.67
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 13.6
RNA-seq analyses of human prostate cancer cells 13.59
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 13.58
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 13.57
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 13.55
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 13.47
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 13.35
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 13.33
Gene expression analysis of dengue-infected cells 13.27
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 13.27
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 13.26
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 13.23
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 13.23
RNA sequencing with KSHV infection and enrichment for circular RNAs 13.23
Genes significantly down or Up-regulated upon RNF219 knockdown 13.21
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 13.06
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 13.06
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 12.97
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 12.92
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 12.84
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 12.73
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 12.66
Landscape of H3K4me3 in human CD19 cells 12.62
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 12.42
Survival of pancreatic cancer cells lacking KRAS function 12.41
Identification of the role of polydom in neurofibromas 12.38
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 12.33
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 12.32
LncRNA-GAS5 negative regulation of YAP-target genes expression 12.31
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 12.26
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 12.0
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 11.87
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 11.87
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 11.84
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 11.84
hTERT promotes cell adhesion and migration independent of telomerase activity 11.77
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 11.76
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 11.76
circRNA-sequencing 11.72
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 11.69
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 11.69
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 11.58
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 11.58
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 11.55
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 11.54
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 11.53
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 11.47
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 11.47
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 11.43
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 11.41
Impact of dieldrin on transcription in Jurkat T cells 11.4
Transcriptome sequencing of K-562 cells 11.34
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 11.33
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 11.32
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 11.22
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 11.18
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 11.14
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 11.08
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 10.98
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 10.88
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 10.87
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 10.83
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 10.81
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 10.74
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 10.64
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 10.64
Changes in human endometrial gland transcriptome over the window of implantation 10.64
Non-coding regions are the main source of tumor-specific antigens 10.59
Non-coding regions are the main source of tumor-specific antigens [human] 10.59
Novel Targeting of Transcription and Metabolism in Glioblastoma 10.58
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 10.52
Depicting early human development and germ cell origin with porcine embryos 10.5
Generation of KRAS signatures using immortalized isogenic lung cells. 10.49
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 10.48
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 10.48
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 10.43
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 10.38
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 10.37
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 10.31
RNAseq of IL-36 stimulated primary human keratinocytes 10.28
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 10.26
Exploring the RNA landscape of endothelial exosomes 10.26
METTL3 promotes translation in human cancer cells 10.25
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 10.24
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 10.2
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 10.18
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 10.15
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 10.13
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 10.12
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 10.11
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 10.09
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 10.05
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 10.05
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 10.04
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 10.03
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 9.96
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 9.96
Control of prostate tumour growth by the long non-coding RNA GHSROS 9.86
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 9.82
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 9.82
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 9.75
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 9.73
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 9.68
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 9.65
Human HAP1 cells before and after nutrient deprivation 9.65
Gene expressions of H9s in different culture systems 9.64
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 9.64
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 9.58
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 9.53
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 9.44
mRNA expression profile of Lymphocytes by high-throuput sequencing 9.4
MYCL and EP400 are required for Max and MCPyV mediated gene activation 9.34
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 9.3
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 9.24
Transcriptome of U251 cells overexpression complement component 7 9.21
ARID1A regulates condensin II distribution and chromosomal partition 9.17
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 9.17
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 9.16
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 9.15
ETV7 and interferon response 9.15
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 9.08
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 9.06
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 9.05
Proteomics identifies a marker signature of MAPKi resistance in melanoma 9.03
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 8.94
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 8.79
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 8.79
TGF-β regulation of miRNA expression in pancreatic cancer 8.74
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 8.7
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 8.62
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 8.62
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 8.58
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 8.56
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 8.53
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 8.53
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 8.53
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 8.53
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 8.48
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 8.48
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 8.44
Role of XRN2 ribonucleolytic activity in RNA metabolism 8.42
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 8.42
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 8.4
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 8.4
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 8.4
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 8.39
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 8.34
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 8.34
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 8.33
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 8.3
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 8.27
Reprogrammed myeloid cell transcriptomes in NSCLC 8.27
A sister of NANOG regulates genes expressed in pre-implantation human development 8.27
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 8.26
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 8.16
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 8.16
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 8.15
Hepatosplenic T cell lymphoma 8.09
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 8.09
Searching for target genes of miR-508/509/506/514 in HCT116 cells 8.01
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 7.93
X-Ray induced DNA-Hydroxymethylation changes 7.89
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 7.89
Gene expression profiling of KSHV-infected periodontal ligament cells 7.87
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 7.76
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 7.76
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 7.75
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 7.75
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 7.73
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 7.73
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 7.73
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 7.69
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 7.6
Microprocessor mediates transcription termination in long noncoding microRNA genes 7.57
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 7.57
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 7.54
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 7.53
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 7.28
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 7.23
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 7.22
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 7.17
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 7.08
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 7.06
Alteration of the microRNA network during the progression of Alzheimer’s disease 7.06
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 7.0
CD73 knockdown effect in pancreatic cancer cell lines 6.87
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 6.8
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 6.8
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 6.8
RNA-sequencing in immortalized human mammary epithelial cells 6.66
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 6.66
UV_24h_GRO-Seq 6.55
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 6.53
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 6.52
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 6.4
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 6.37
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 6.37
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 6.33
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 6.32
Regulatory network controlling tumor-promoting inflammation in human cancers 6.32
MHC Transcriptomic landscape at haplotype-specific resolution 6.31
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 6.2
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 6.16
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 6.14
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 6.04
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 5.95
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 5.87
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 5.85
Fibroblasts in cholesteatoma activate osteoclasts. 5.83
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 5.82
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 5.82
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 5.75
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 5.7
An optimization system for isolating and sequencing of single human colon cancer cells 5.62
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 5.54
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 5.34
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 5.34
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 5.31
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 5.31
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 5.3
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 5.29
Gene expression profile of human placenta from T. Cruzi infected mothers 5.24
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 5.21
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 5.12
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 5.11
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 5.09
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 5.04
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 5.02
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 5.02
siRNA-mediated knockdown 5.01
Effect of PBK knockdown on C4-2 cell transcriptome 4.98
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 4.97
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 4.95
The circadian transcriptional landscape in primary human mammary epithelial cells 4.92
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 4.81
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 4.8
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 4.78
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 4.78
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 4.75
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 4.74
JAK dependent survival of ALK- ALCL 4.71
Aneuploidy triggers an immune response 4.64
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 4.61
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 4.54
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 4.54
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 4.52
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 4.5
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 4.5
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 4.49
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 4.34
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 4.28
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 4.28
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 4.25
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 4.23
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 4.23
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 4.23
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 4.17
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 4.14
In situ CAPTURE of chromatin interactions by biotinylated dCas9 4.14
Capturing the Interactome of Newly Transcribed RNA 4.12
Capturing the Interactome of Newly Transcribed RNA (RICK) 4.12
Epigenomic conservation of transposable element silencing [RNA-seq] 4.12
Epigenomic conservation of transposable element silencing 4.12
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 4.09
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 4.09
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 4.07
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 4.01
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 3.98
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 3.88
Gene expression analysis of human hepatocellular cancers 3.84
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 3.83
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 3.82
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 3.81
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 3.75
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 3.73
6mer seed toxicity in tumour suppressive microRNAs 3.71
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 3.68
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 3.66
Gene expression profile of multiple myeloma cell lines treated with CB-5083 3.61
Aortic Valve Tissue: Stenosis vs. Sclerosis 3.61
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 3.58
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 3.49
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 3.48
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 3.4
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 3.33
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 3.29
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 3.2
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 3.2
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 3.18
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 3.16
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 3.16
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 3.11
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 3.02
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 3.02
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 3.01
The role of the Calcium-Sensing receptor in colorectal cancer 3.01
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 2.95
The cohesin release factor WAPL restricts chromatin loop extension. 2.9
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 2.9
6mer seed toxicity in viral microRNAs 2.86
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 2.75
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 2.72
The contribution of Alu exons to the human proteome 2.65
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 2.63
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 2.63
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 2.63
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 2.6
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 2.56
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 2.53
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 2.5
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 2.49
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 2.46
Copper Regulation of HIF-1 Transcription Activity 2.46
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 2.46
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 2.44
Impact on erythroid progenitor type on erythroid differntiation 2.37
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 2.33
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 2.29
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 2.29
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 2.24
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 2.24
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 2.19
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 2.16
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 2.13
Transcriptomes in healthy and CHB fetal hearts 2.07
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 2.04
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 2.04
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 2.03
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 2.01
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 2.01
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 1.98
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 1.97
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 1.96
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 1.93
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 1.92
Zika virus infection reprograms global transcription of host cells to allow sustained infection 1.9
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 1.88
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 1.84
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 1.76
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 1.73
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 1.72
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 1.65
Effects of transcription on genome - nuclear lamina interactions 1.65
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 1.5
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 1.46
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 1.46
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 1.45
SNHG5 siRNA knock down in HCT116 cells 1.39
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 1.38
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 1.38
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 1.37
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 1.35
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 1.35
EGR1-controlled transcriptome of T HESCs 1.33
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 1.3
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 1.28
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 1.25
WNT signaling memory is required for ACTIVIN to function as a morphogen 1.24
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 1.24
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 1.16
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 1.16
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 1.11
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 1.07
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 1.01
High-resolution comparative analysis of great ape genomes 0.91
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 0.86
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 0.86
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.82
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 0.79
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.72
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.72
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.64
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.64
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 0.58
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 0.48
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.4
Leucegene: ALL sequencing 0.38
A code of mono-phosphorylation modulates the function of RB. 0.3
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.27
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.21
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.21
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 0.18
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.13
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.13
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.13
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.12
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.07
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 0.04
Gene expression changes after LOC550643 silencing 0.02
Modulation of nonsense-mediated decay by rapamycin 0.02
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.02
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.01
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation